Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2006, Article ID 12587, 5 pages
http://dx.doi.org/10.1155/MI/2006/12587
Research Communication

ApoE Polymorphism Is Associated With C-Reactive Protein in Low-HDL Family Members and in Normolipidemic Subjects

1Division of Cardiology, Department of Internal Medicine, Helsinki University Central Hospital, Haartmaninkatu 4, P.O. Box 340, HUS 00029, Finland
2Baker Medical Research Institute, Melbourne, Victoria, Australia
3Department of Molecular Medicine, Biomedicum, National Public Health Institute, Helsinki 00251, Finland

Received 30 December 2005; Revised 15 March 2006; Accepted 20 March 2006

Copyright © 2006 Juhani Kahri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R Ross, “Atherosclerosis—an inflammatory disease,” New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar
  2. P Libby, P M Ridker, and A Maseri, “Inflammation and atherosclerosis,” Circulation, vol. 105, no. 9, pp. 1135–1143, 2002. View at Publisher · View at Google Scholar
  3. P M Ridker, N Rifai, L Rose, J E Buring, and N R Cook, “Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events,” New England Journal of Medicine, vol. 347, no. 20, pp. 1557–1565, 2002. View at Publisher · View at Google Scholar
  4. S Blankenberg, S Barbaux, and L Tiret, “Adhesion molecules and atherosclerosis,” Atherosclerosis, vol. 170, no. 2, pp. 191–203, 2003. View at Publisher · View at Google Scholar
  5. M J Davies, J L Gordon, A J Gearing et al., “The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis,” Journal of Pathology, vol. 171, no. 3, pp. 223–229, 1993. View at Publisher · View at Google Scholar
  6. K D O'Brien, T O McDonald, A Chait, M D Allen, and C E Alpers, “Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content,” Circulation, vol. 93, no. 4, pp. 672–682, 1996. View at Google Scholar
  7. S J Hwang, C M Ballantyne, R A Sharrett et al., “Circulating adhesion molecules VCAM-1, ICAM-1 and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. The atherosclerosis risk in communities (ARIC) study,” Circulation, vol. 96, no. 12, pp. 4219–4225, 1997. View at Google Scholar
  8. P M Ridker, C H Hennekens, B Roitman-Johnson, M J Stampfer, and J Allen, “Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men,” Lancet, vol. 351, no. 9096, pp. 88–92, 1998. View at Publisher · View at Google Scholar
  9. L E Rohde, R T Lee, J Rivero et al., “Circulating cell adhesion molecules are correlated with ultrasound-based assesment of carotid atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 11, pp. 1765–1770, 1998. View at Google Scholar
  10. J Davignon, J S Cohn, L Mabile, and L Bernier, “Apolipoprotein E and atherosclerosis: insight from animal and human studies,” Clinica Chimica Acta, vol. 286, no. 1-2, pp. 115–143, 1999. View at Publisher · View at Google Scholar
  11. M Van Oosten, P CN Rensen, E S Van Amersfoort et al., “Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat Gram-negative sepsis,” Journal of Biological Chemistry, vol. 276, no. 12, pp. 8820–8824, 2001. View at Publisher · View at Google Scholar
  12. K Bach-Ngohou, H Nazih, F Nazih-Sanderson et al., “Negative and independent influence of apolipoprotein E on C-reactive protein (CRP) concentration in obese adults. Potential anti-inflammatory role of apoE in vivo,” International Journal of Obesity, vol. 25, no. 12, pp. 1752–1758, 2001. View at Publisher · View at Google Scholar
  13. A Paul, K WS Ko, L Li et al., “C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice,” Circulation, vol. 109, no. 5, pp. 647–655, 2004. View at Publisher · View at Google Scholar
  14. Y Song, M J Stampfer, and S Liu, “Meta-analysis: apolipoprotein E genotypes and risk of coronary heart disease,” Annals of Internal Medicine, vol. 141, no. 2, pp. 137–147, 2004. View at Google Scholar
  15. W J Strittmatter and A D Roses, “Apolipoprotein E and Alzheimer's disease,” Annual Review of Neuroscience, vol. 19, pp. 53–77, 1996. View at Publisher · View at Google Scholar
  16. M Mänttäri, V Manninen, T Palosuo, and C Ehnholm, “Apolipoprotein E polymorphism and C-reactive protein in dyslipidemic middle aged men,” Atherosclerosis, vol. 156, no. 1, pp. 237–238, 2001. View at Google Scholar
  17. W März, H Sxharnagl, M M Hoffman, B O Boehm, and B R Winkelmann, “The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study),” European Heart Journal, vol. 25, no. 23, pp. 2109–2119, 2004. View at Google Scholar
  18. R Judson, C Brain, B Dain, A Windemuth, G Ruano, and C Red, “New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals,” Atherosclerosis, vol. 177, no. 2, pp. 345–351, 2004. View at Publisher · View at Google Scholar
  19. H P Grocott, M F Newman, H El-Moalem, D Bainbridge, A Butler, and D T Laskowitz, “Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass,” Journal of Thoracic and Cardiovascular Surgery, vol. 122, no. 3, pp. 622–623, 2001. View at Publisher · View at Google Scholar
  20. J R Lynch, W Tang, H Wang et al., “ApoE genotype and an apoE-mimetic peptide modify the systemic and central nervous system inflammatory response,” Journal of Biological Chemistry, vol. 273, no. 49, pp. 48529–48533, 2003. View at Publisher · View at Google Scholar
  21. G W Cockerill, K A Rye, J R Gamble, M A Vadas, and P J Barter, “High-density lipoprotein inhibit cytokine-induced expression of endothelial cell adhesion molecule,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, no. 11, pp. 1987–1994, 1995. View at Google Scholar
  22. G W Cockerill, T Y Huehns, A Weerasinghe et al., “Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation,” Circulation, vol. 103, no. 1, pp. 108–112, 2001. View at Google Scholar
  23. L Calabresi, G Franceschini, C R Sirtori et al., “Inhibition of VCAM-1 expression in endothelial cells by reconstituted high-density lipoproteins,” Biochemical and Biophysical Research Communications, vol. 1238, no. 1, pp. 61–65, 1997. View at Publisher · View at Google Scholar
  24. U JF Tietge, C Maugeais, W Cain et al., “Overexpression of secretory phospholipase A(2) causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I,” Journal of Biological Chemistry, vol. 275, no. 14, pp. 10077–10084, 1999. View at Publisher · View at Google Scholar
  25. U JF Tietge, C Maugeais, S Lund-Katz, D Grass, F C deBeer, and D J Rader, “Human secretory phospholipase A2 (sPLA2) mediates decreased plasma levels of HDL-cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 7, pp. 1213–1218, 2002. View at Publisher · View at Google Scholar
  26. J Heeren, T Grewal, A Laatsch et al., “Recycling of apoprotein E is associated with cholesterol efflux and high density lipoprotein internalization,” Journal of Biological Chemistry, vol. 278, no. 16, pp. 14370–14378, 2003. View at Publisher · View at Google Scholar
  27. C Alagona, A Soro-Paavonen, K Ylitalo, R Salonen, J T Salonen, and M-R Taskinen, “A low high density lipoprotein (HDL) level is associated with carotid artery intima-media thickness in asymptomatic members of low HDL families,” Atherosclerosis, vol. 165, no. 2, pp. 309–316, 2002. View at Publisher · View at Google Scholar
  28. L M Havekes, P de Knijff, U Beisiegel, J Havinga, M Smit, and E Klasen, “A rapid micromethod for apolipoprotein E phenotyping directly in serum,” Journal of Lipid Research, vol. 28, no. 4, pp. 455–463, 1987. View at Google Scholar
  29. S W Barger and A D Harmon, “Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E,” Nature, vol. 388, no. 6645, pp. 878–881, 1997. View at Publisher · View at Google Scholar
  30. M A Austin, C Zhang, S E Humphries et al., “Heritability of C-reactive protein and association with apolipoprotein E genotypes in Japanese Americans,” Annals of Human Genetics, vol. 68, no. 3, pp. 179–188, 2004. View at Publisher · View at Google Scholar
  31. K J Mukamal, M Cushman, M A Mittleman, R P Tracy, and D S Siscovick, “Alcohol consumption and inflammatory markers in older adults: the Cardiovascular Health Study,” Atherosclerosis, vol. 173, no. 1, pp. 79–87, 2004. View at Publisher · View at Google Scholar